SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns blowout quarterly results and stronger outlook, supported by AI-driven memory demand and expectations of tight supply through 2028, are the main focus. Traders are debating the muted share reaction: some cite high expectations, margin pressure, capex and memory-cycle risk, while bulls argue the demand outlook remains strong and is not reflected in the valuation.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMYs sharp rebound has fueled breakout and accumulation chatter, with bullish traders pointing to the Panasonic/Jasmy Smart Render collaboration and reported JasmyChain activity as signs of growing utility. Others argue adoption remains limited and raise exchange-delisting and weak-performance concerns, so the rallys durability is contested.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBMs self-hosted deployment option for its AI coding platform Bob is drawing attention, with traders viewing tighter enterprise data control as a boost to its AI offering. Reactions are mixed: some welcome the announcement and see momentum, while others expect the stock to fade or are taking profits.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Accentures fiscal fourth-quarter results beat expectations, with record annual bookings and a positive fiscal 2027 growth outlook driving a sharp rally. Bulls see bookings as evidence that enterprise AI and consulting demand remain resilient, while skeptics argue growth is modest and AI could still disrupt the traditional consulting business.

Liquidia Corp. operates as a holding company which engages through its subsidiary in developing and commercializing biopharmaceutical products and novel products development used in PRINT technology to transform the lives of patients. The company was founded in June 2004 and is headquartered in Morrisville, NC.

Liquidia Corp

A Delaware court found that Liquidias Yutrepia infringes two United Therapeutics patent claims covering its PH-ILD use, driving a steep selloff as traders weigh possible label restrictions or broader limits on sales. Liquidia plans to appeal and pursue removal of the PH-ILD indication, but the remedy is unresolved; the community is split between calling the shares uninvestable and viewing the drop as an overreaction.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as long-term Treasury yields reach multi-decade highs, with traders pointing to persistent inflation, elevated oil prices, strong growth and debt concerns behind the bond selloff. The community is split between expecting further losses as yields stay elevated and viewing the ETFs steep decline and higher yields as a buying opportunity.

Armada Acquisition Corp. II is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combinations with one or more businesses. The company was founded on October 3, 2024 and is headquartered in Miami, FL.

Armada Acquisition Corp. II - Ordinary Shares- Class A

Evernorth Holdings Inc.

The reported approval of Evernorths business combination with Armada is driving attention, advancing the XRP-treasury company toward its planned Nasdaq listing. Traders are reacting to the sharp move with bullish momentum bets, while debating the still-uncertain redemption count, post-merger float, closing details, and warrant risks.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A sharp, high-volume breakout without a clearly identified new company announcement is driving attention. Traders are debating whether reported institutional buying and short interest could support further momentum, while others warn the move may fade.

AST SpaceMobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an intellectual property and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobiles shipment of BlueBirds 1416 toward Cape Canaveral is drawing attention, alongside bullish discussion of BB11s deployment. Bulls see progress in the constellation rollout, while skeptics note that no launch date was provided and question whether the shipment addresses concerns about slow launch cadence; buyout chatter remains speculation.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLakes BLA submission for sonelokimab to treat hidradenitis suppurativa is the main focus, with traders viewing the filing as a key regulatory milestone but noting the muted share reaction. Discussion centers on uncertainty over priority review and the FDAs upcoming decision on whether to accept the application, alongside concerns about management communication and earlier clinical data.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


Feed

News

Sentiment

Info

Historical Prices

GEKKO Gekko HQ

Fundamentals

Latest GEKKO News